U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 13

1.
The antihyperlipidemic effect of a combined supplement of standardized dry extracts of amla (Emblica officinalis), walnut (Juglans regia), olive (Olea europaea) and red yeast rice (Monascus purpureus) powder: Reduction in circulatory low-density lipoprotein-cholesterol (LDL-C) and remnant cholesterol (RC) levels in patients with hypercholesterolemia
Michel P. Hermans, Yvan Dierckxsens, Isabelle Janssens, Laurence Seidel, Adelin Albert, Sylvie A. Ahn, Michel F. Rousseau, Amjad Khan
Front Pharmacol. 2023; 14: 1280234. Published online 2023 Nov 27. doi: 10.3389/fphar.2023.1280234
PMCID:
PMC10712314
ArticlePDF–1.1M
2.
Clinical effects of Emblica officinalis fruit consumption on cardiovascular disease risk factors: a systematic review and meta-analysis
Paul D. S. Brown, Nicole Ketter, Mathew Vis-Dunbar, Brodie M. Sakakibara
BMC Complement Med Ther. 2023; 23: 190. Published online 2023 Jun 9. doi: 10.1186/s12906-023-03997-8
PMCID:
PMC10251691
ArticlePDF–2.5M
3.
Attenuation of Hyperlipidemia by Medicinal Formulations of Emblica officinalis Synergized with Nanotechnological Approaches
Puttasiddaiah Rachitha, Krupashree Krishnaswamy, Renal Antoinette Lazar, Vijai Kumar Gupta, Baskaran Stephen Inbaraj, Vinay Basavegowda Raghavendra, Minaxi Sharma, Kandi Sridhar
Bioengineering (Basel) 2023 Jan; 10(1): 64. Published online 2023 Jan 4. doi: 10.3390/bioengineering10010064
PMCID:
PMC9854976
ArticlePDF–2.3M
4.
Current advances on the phytochemical composition, pharmacologic effects, toxicology, and product development of Phyllanthi Fructus
Xiaoyu Yan, Qiuju Li, Lin Jing, Shuangyue Wu, Wei Duan, Yan Chen, Dayi Chen, Xiaoqi Pan
Front Pharmacol. 2022; 13: 1017268. Published online 2022 Oct 19. doi: 10.3389/fphar.2022.1017268
PMCID:
PMC9626985
ArticlePDF–2.5M
5.
Molecular Mechanisms of Cancer Prevention by Gooseberry (Phyllanthus emblica)
Gaurav Kumar, Venkateshwar Madka, Gopal Pathuri, Vishal Ganta, Chinthalapally V. Rao
Nutr Cancer. Author manuscript; available in PMC 2022 Aug 1.
Published in final edited form as: Nutr Cancer. 2022; 74(7): 2291–2302. Published online 2021 Nov 28. doi: 10.1080/01635581.2021.2008988
PMCID:
PMC9341453
ArticlePDF–1.3M
6.
Functional and Nutraceutical Significance of Amla (Phyllanthus emblica L.): A Review
Maryam Gul, Zhi-Wei Liu, Iahtisham-Ul-Haq, Roshina Rabail, Fatima Faheem, Noman Walayat, Asad Nawaz, Muhammad Asim Shabbir, Paulo E. S. Munekata, José M. Lorenzo, Rana Muhammad Aadil
Antioxidants (Basel) 2022 May; 11(5): 816. Published online 2022 Apr 22. doi: 10.3390/antiox11050816
PMCID:
PMC9137578
ArticlePDF–1.7M
7.
A Systematic Review and Meta-Analysis of Ayurvedic Herbal Preparations for Hypercholesterolemia
Dinesh Gyawali, Rini Vohra, David Orme-Johnson, Sridharan Ramaratnam, Robert H. Schneider
Medicina (Kaunas) 2021 Jun; 57(6): 546. Published online 2021 May 28. doi: 10.3390/medicina57060546
PMCID:
PMC8229657
ArticlePDF–4.2M
8.
A Randomized, Triple-Blind, Placebo-Controlled, Add-On Clinical Trial to Evaluate the Efficacy of Emblica officinalis in Uncontrolled Hypertension
Samad Ghaffari, Maryam Navabzadeh, Mojtaba Ziaee, Ali Ghobadi, Roshanak Ghods, Fataneh Hashem-Dabaghian
Evid Based Complement Alternat Med. 2020; 2020: 8592869. Published online 2020 Oct 7. doi: 10.1155/2020/8592869
PMCID:
PMC7563076
ArticlePDF–407K
9.
Polyphenolic compounds of amla prevent oxidative stress and fibrosis in the kidney and heart of 2K1C rats
Md. Mizanur Rahman, Khandoker Usran Ferdous, Shraboni Roy, Iffat Ara Nitul, Fariha Mamun, Md. Hemayet Hossain, Nusrat Subhan, Md Ashraful Alam, Md. Areeful Haque
Food Sci Nutr. 2020 Jul; 8(7): 3578–3589. Published online 2020 May 20. doi: 10.1002/fsn3.1640
PMCID:
PMC7382108
ArticlePDF–2.0M
10.
A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia
Haridas Upadya, S. Prabhu, Aravinda Prasad, Deepa Subramanian, Swati Gupta, Ajay Goel
BMC Complement Altern Med. 2019; 19: 27. Published online 2019 Jan 22. doi: 10.1186/s12906-019-2430-y
PMCID:
PMC6341673
ArticlePDF–1.4M
11.
A systematic review on the cardiovascular pharmacology of Emblica officinalis Gaertn.
Fataneh Hashem-Dabaghian, Mojtaba Ziaee, Samad Ghaffari, Farzaneh Nabati, Saeed Kianbakht
J Cardiovasc Thorac Res. 2018; 10(3): 118–128. Published online 2018 Sep 25. doi: 10.15171/jcvtr.2018.20
PMCID:
PMC6203864
ArticlePDF–745K
12.
Protective effects of Ethanolic Extract of Emblica officinalis (amla) on Cardiovascular Pathophysiology of Rats, Fed with High Fat Diet
Pallavi Shantkumar Kanthe, Bheemshetty S Patil, Shrilaxmi C Bagali, R Chandramouli Reddy, Manjunatha R Aithala, Kusal K Das
J Clin Diagn Res. 2017 Sep; 11(9): CC05–CC09. Published online 2017 Sep 1. doi: 10.7860/JCDR/2017/28474.10628
PMCID:
PMC5713720
ArticlePDF–456K
13.
Evaluation of Phyllanthus emblica extract on cold pressor induced cardiovascular changes in healthy human subjects
Nishat Fatima, Usharani Pingali, Raveendranadh Pilli
Pharmacognosy Res. 2014 Jan-Mar; 6(1): 29–35. doi: 10.4103/0974-8490.122914
PMCID:
PMC3897005
ArticlePDF–478K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center